Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with primary biliary cholangitis Read more
Ipsen announces positive outcome of FDA Advisory Committee on investigational palovarotene for fibrodysplasia ossificans progressiva Read more